Research ArticleArticle
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center
Onorina Berardicurti, Viktoriya Pavlych, Ilenia Di Cola, Piero Ruscitti, Paola Di Benedetto, Luca Navarini, Annalisa Marino, Paola Cipriani and Roberto Giacomelli
The Journal of Rheumatology October 2021, jrheum.210441; DOI: https://doi.org/10.3899/jrheum.210441
Onorina Berardicurti
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Viktoriya Pavlych
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Ilenia Di Cola
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Piero Ruscitti
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Paola Di Benedetto
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Luca Navarini
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Annalisa Marino
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Paola Cipriani
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
Roberto Giacomelli
HarmonicSS project (HORIZON H2020) supported this research. O. Berardicurti, MD, V. Pavlich, MD, I. Di Cola, MD, P. Ruscitti, PhD, P. Di Benedetto, PhD, P. Cipriani, PhD, Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila; L. Navarini, MD, A. Marino, MD, Roberto Giacomelli, MD, PhD, Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy. V. Pavlich and I. Di Cola contributed equally to this work. P. Cipriani and R. Giacomelli are co–senior authors. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Giacomelli, Rheumatology and Immunology Unit, Department of Medicine, University of Rome 'Campus Biomedico', Rome, Italy. Email: r.giacomelli@unicampus.it, roberto.giacomelli@univaq.it. Accepted for publication October 4, 2021.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center
Onorina Berardicurti, Viktoriya Pavlych, Ilenia Di Cola, Piero Ruscitti, Paola Di Benedetto, Luca Navarini, Annalisa Marino, Paola Cipriani, Roberto Giacomelli
The Journal of Rheumatology Oct 2021, jrheum.210441; DOI: 10.3899/jrheum.210441
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center
Onorina Berardicurti, Viktoriya Pavlych, Ilenia Di Cola, Piero Ruscitti, Paola Di Benedetto, Luca Navarini, Annalisa Marino, Paola Cipriani, Roberto Giacomelli
The Journal of Rheumatology Oct 2021, jrheum.210441; DOI: 10.3899/jrheum.210441